Pre-made Refanezumab benchmark antibody ( Whole mAb, anti-MAG therapeutic antibody, Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-474

Pre-Made Refanezumab biosimilar, Whole mAb, Anti-MAG Antibody: Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Refanezumab (GSK249320) is a monoclonal antibody designed for the recovery of motor function after stroke.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-474-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Refanezumab biosimilar, Whole mAb, Anti-MAG Antibody: Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75 therapeutic antibody
INN Name Refanezumab
TargetMAG
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesGlaxoSmithKline
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedCNS trauma;Stroke
Development Techna